IR News

2024.10.10IR

The Effects of Designating Collategene (HGF gene therapy product) as Breakthrough Therapy

2024.08.23IR

Notice Concerning Termination of Exclusive Sales Rights Agreements for HGF Gene Therapy Product "Collategene"

2024.08.09IR

Consolidated Financial Report for the Second Quarter 2024

2024.07.31IR

Notice Concerning the Conclusion of an Agreement with the Gunma Health Promotion Foundation for Extended Newborn Screening in Gunma Prefecture

2024.07.29IR

Notice Regarding the Recognition of Costs Associated with the Termination of Sales of the Products

【 Corporate Brochure 】

Introduction of company overview and our business

PDF